warnings
WARNING: Administration of folic acid alone is improper therapy for pernicious anemia and other megaloblastic anemias in which vitamin B12 is deficient.
Vitramyn
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- Vitramyn
- Generic name
- FOLIC ACID
- Manufacturer
- PureTek Corporation
- Product type
- HUMAN PRESCRIPTION DRUG
- SPL set ID
- c8af7616-5178-6df0-e053-2a95a90a334d
- SPL ID
- 548ee394-41b9-d346-e063-6394a90a0773
- Version
- 5
- Effective date
- 2026-06-18
- Source export date
- 2026-09-28
- Source partition
- 11
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0011-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-09-28/aa96b5a2be6b394393acd0090f6948bdf99e0e8e00666f81608929c8fa83db77/drug-label-0011-of-0014.json.zip
- Source manifest SHA-256
- cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
- Import run
- 20260929T050834Z
- Imported at
- 2026-09-29 06:18:17
| Harmonized routes |
|---|
| ORAL |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| brand name | Vitramyn | openfda.brand_name | |
| generic name | FOLIC ACID | openfda.generic_name | |
| manufacturer name | PureTek Corporation | openfda.manufacturer_name | |
| ndc | package | 59088-193-54 | openfda.package_ndc |
| ndc | product | 59088-193 | openfda.product_ndc |
| ndc11 | package | 59088019354 | derived:openfda.package_ndc |
| spl id | 548ee394-41b9-d346-e063-6394a90a0773 | id | |
| spl set id | c8af7616-5178-6df0-e053-2a95a90a334d | set_id | |
| unii | 25X51I8RD4 | openfda.unii | |
| unii | 3LE3D9D6OY | openfda.unii | |
| unii | TLM2976OFR | openfda.unii | |
| unii | H0G9379FGK | openfda.unii | |
| unii | 935E97BOY8 | openfda.unii | |
| unii | W00LYS4T26 | openfda.unii | |
| unii | PQ6CK8PD0R | openfda.unii | |
| unii | A150AY412V | openfda.unii | |
| unii | SOI2LOH54Z | openfda.unii | |
| unii | 3A3U0GI71G | openfda.unii | |
| unii | 81AH48963U | openfda.unii | |
| unii | P6YC3EG204 | openfda.unii | |
| unii | 8K0I04919X | openfda.unii | |
| unii | WR1WPI7EW8 | openfda.unii | |
| unii | 68Y4CF58BV | openfda.unii | |
| unii | 1C6V77QF41 | openfda.unii | |
| unii | H6241UJ22B | openfda.unii |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Adverse reactions cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
adverse reactions
Adverse Reactions: Allergic sensitization has been reported following both oral and parenteral administration of folate derivatives. Adverse reactions have been reported with individual vitamins and minerals, generally at levels substantially higher than those contained in this product. However, allergic and idiosyncratic reactions may occur even at lower levels. Gastrointestinal intolerance (e.g., nausea, abdominal discomfort) has been reported with certain vitamins and minerals, particularly at higher doses. Call your doctor about side effects. To report side effects, call PureTek Corporation at 1-877-921-7873 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.